ClassID:

94104

C07D209/26 - CPC Classification

Classification description:

Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring; Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring; Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom

Sub-classes:
Recent Application in this class:
#1
20260116854
2026-04-30

METHOD FOR PREPARING FMOC-TRP(BOC)-OH

#2
20250270170
2025-08-28

2,3-DIMETHOXY-5-METHYL-1,4-BENZOQUINONE ALKYL ALCOHOL DERIVATIVE AND USE THEREOF

#3
20250154145
2025-05-15

OXER1 ANTAGONISTS AND USES THEREOF

#4
20250109166
2025-04-03

PROCESS FOR MANUFACTURING MACROCYCLIC PEPTIDES

#5
20250109104
2025-04-03

SQUARAINE FLUOROPHORES

#6
20240391884
2024-11-28

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

#7
20240286998
2024-08-29

FLUORINATED TRYPTAMINE COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME

#8
20240109842
2024-04-04

ACRYLAMIDE COMPOUNDS

#9
20240059656
2024-02-22

A TAUTOMERIC LIGAND ENABLES BIOMIMETIC C-H HYDROXYLATION WITH MOLECULAR OXYGEN

#10
20240002332
2024-01-04

Small Molecule Inhibitors of SARS-CoV-2 Infections

#11
20230373900
2023-11-23

CYCLOPROPENIUM COMPOUNDS, PROCESS FOR THEIR PREPARATION AND USE

#12
20230250049
2023-08-10

PROCESS FOR THE PREPARATION OF ORTHO-HALOGENATED PHENYLALANINE COMPOUNDS

#13
20230232828
2023-07-27

SULPHONAMIDES AS METHIONINE METABOLIC PATHWAY INHIBITORS

#14
20230174480
2023-06-08

FLUOROGENIC DIMER COMPOUND, USEFUL AS A PROBE FOR DETECTION OF ENDOGENOUS RECEPTORS

#15
20230145074
2023-05-11

Indole compounds and their use

#16
20230079631
2023-03-16

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

#17
20210251960
2021-08-19

Indomethacin analogs for the treatment of castrate-resistant prostate cancer

#18
20210230129
2021-07-29

Compounds and compositions for treating conditions associated with NLRP activity

#19
20210198197
2021-07-01

METHOD FOR SYNTHESIZING INDOMETHACIN AND ANALOGUE THEREOF

#20
20210179604
2021-06-17

Indole compounds and their use

#21
20200354353
2020-11-12

Indole compounds and their use

#22
20200339511
2020-10-29

Substituted indoline derivatives as dengue viral replication inhibitors

#23
20200329705
2020-10-22

Sulphonamides as methionine metabolic pathway inhibitors

#24
20200299235
2020-09-24

Substituted indoline derivatives as dengue viral replication inhibitors

#25
20200199062
2020-06-25

METHOD AND SYSTEM FOR SEPARATING ONE OR MORE AMINO ACIDS FROM A WHOLE STILLAGE BYPRODUCT PRODUCED IN A CORN DRY MILLING PROCESS

#26
20190350903
2019-11-21

INDOMETHACIN ANALOGS FOR THE TREATMENT OF CASTRATE-RESISTANT PROSTATE CANCER

#27
20190314352
2019-10-17

ADMINISTRATION OF DIPEPTIDYL PEPTIDASE INHIBITORS

#28
20190169124
2019-06-06

Derivatives of indole for the treatment of cancer, viral infections and lung diseases

#29
20190112267
2019-04-18

Small molecule N-(alpha-peroxy) indole compounds and methods of use

#30
20190112266
2019-04-18

Substituted indoline derivatives as dengue viral replication inhibitors

#31
20180271835
2018-09-27

Indomethacin analogs for the treatment of castrate-resistant prostate cancer

#32
20180258039
2018-09-13

Substituted indole Mcl-1 inhibitors

#33
20180022701
2018-01-25

4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof

#34
20180022700
2018-01-25

Compound containing indoleacetic acid core structure and use thereof

#35
20170369417
2017-12-28

TAK1 kinase inhibitors, compositions, and uses related thereto

#36
20170233342
2017-08-17

Derivatives of indole for the treatment of cancer, viral infections and lung diseases

#37
20160303082
2016-10-20

Indomethacin analogs for the treatment of castrate-resistant prostate cancer

#38
20160264621
2016-09-15

THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USE

#39
20160214934
2016-07-28

Substituted indole Mcl-1 inhibitors

#40
20160159740
2016-06-09

Indole 3-carbinol derivatives

#41
20160096828
2016-04-07

Indole-1-carboxamides as kinase inhibitors

#42
20160096791
2016-04-07

Direct anti-markovnikov addition of acids to alkenes

#43
20160031804
2016-02-04

Augmenting moieties for anti-inflammatory compounds

#44
20150315143
2015-11-05

N-heterocyclic carbene-catalyzed synthesis of 2-aryl indoles

#45
20150259286
2015-09-17

7-hydroxy-indolinyl antagonists of P2Yreceptor

#46
20150218096
2015-08-06

4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof

#47
20150191434
2015-07-09

3-cyclohexenyl and cyclohexyl substituted indole and indazole compounds as RORgammaT inhibitors and uses thereof

#48
20150158834
2015-06-11

Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics

#49
20150094330
2015-04-02

Compounds and methods for skin repair

#50
20150090936
2015-04-02

Large stokes shift dyes

#51
20140371261
2014-12-18

Indomethacin analogs for the treatment of castrate-resistant prostate cancer

#52
20140356336
2014-12-04

Method for inducing differentiation enabling tumorigenesis of IPS cells to be suppressed

#53
20140256928
2014-09-11

Protecting group for indole group, nucleic acid-synthesizing amidite and nucleic acid-synthesizing method

#54
20140249199
2014-09-04

TAK1 kinase inhibitors, compositions, and used related thereto

#55
20140135520
2014-05-15

Method for manufacturing optically active carboxylic acid ester

#56
20140057959
2014-02-27

NOVEL COMPOUNDS DERIVED FROM TAURINE, PROCESS OF THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE

#57
20140057909
2014-02-27

Indole derivative or pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic diseases containing same as active ingredient

#58
20140005386
2014-01-02

p53-Mdm2 antagonists

#59
20130224115
2013-08-29

NON-RADIOACTIVE AGENTS FOR NEUROBLASTOMA IMAGING

#60
20130158070
2013-06-20

CONJUGATES OF POLYUNSATURATED FATTY ACIDS AND AMINE-CONTAINING COMPOUNDS AND USES THEREOF

#61
20120323006
2012-12-20

Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics

#62
20110313129
2011-12-22

LARGE STOKES SHIFT DYES

#63
20110253944
2011-10-20

Organic semiconductor compound, method for preparing the same, and organic semiconductor composition, and organic semiconductor thin film and element containing the same

#64
20110212982
2011-09-01

Administration of Dipeptidyl Peptidase Inhibitors

#65
20110195967
2011-08-11

2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them

#66
20110118455
2011-05-19

Protecting group for indole group, nucleic acid-synthesizing amidite and nucleic acid-synthesizing method

#67
20110118303
2011-05-19

Compounds derived from taurine, process of their preparation and pharmaceutical compositions containing these

#68
20100267726
2010-10-21

2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them

#69
20100210036
2010-08-19

PPAR active compounds

#70
20100137363
2010-06-03

Substituted Indoles And Methods Of Their Use

#71
20100056783
2010-03-04

Process for the preparation of statins and their pharmaceutically acceptable salts thereof

#72
20090252678
2009-10-08

COX-2-TARGETED IMAGING AGENTS

#73
20090239909
2009-09-24

TREATMENT OF METABOLIC SYNDROME WITH LACTAMS

#74
20090227599
2009-09-10

SULFONYL-SUBSTITUTED BICYCLIC COMPOUNDS AS MODULATORS OF PPAR

#75
20090118290
2009-05-07

Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity

#76
20090069428
2009-03-12

CATALYTIC ANTIOXIDANTS AND METHODS OF USE

#77
20080300260
2008-12-04

Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mGlu2 receptor)

#78
20080199454
2008-08-21

Caspase inhibitor prodrugs

#79
20080188532
2008-08-07

Indole compound and use thereof

#80
20080153802
2008-06-26

Alpha-helical mimetics

#81
20080096913
2008-04-24

PPAR active compounds

#82
20080085891
2008-04-10

Asthma and allergic inflammation modulators

#83
20080058548
2008-03-06

Concise β-amino acid synthesis via organocatalytic aminomethylation

#84
20080045581
2008-02-21

PPAR active compounds

#85
20070155818
2007-07-05

PPAR active compounds

#86
20070149603
2007-06-28

PPAR active compounds

#87
20070072935
2007-03-29

Catalytic antioxidants and methods of use

#88
20070060528
2007-03-15

ADMINISTRATION OF DIPEPTIDYL PEPTIDASE INHIBITORS

#89
20070043101
2007-02-22

Substituted indoles and methods of their use

#90
20070015755
2007-01-18

NOVEL COMPOUNDS AND COMPOSITIONS AS PROTEASE INHIBITORS

#91
20060223842
2006-10-05

2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them

#92
20060205736
2006-09-14

Sulfonyl-substituted bicyclic compounds as modulators of PPAR

#93
20060167046
2006-07-27

Histamine h3 receptor antagonists, preparation and therapeutic uses

#94
20060063937
2006-03-23

Geminally di-substituted NSAID derivatives as Aβ42 lowering agents

#95
20060063760
2006-03-23

Hydroxamic acids useful in the treatment of hyper-proliferative disorders

#96
20050288354
2005-12-29

PPAR active compounds

#97
20050250839
2005-11-10

Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity

#98
20050234244
2005-10-20

Synthesis of COX-2 and FAAH inhibitors

#99
20050234030
2005-10-20

Modulators of CRTH2, COX-2 and FAAH

#100
20050038246
2005-02-17

PPAR active compounds

#101
20050032747
2005-02-10

COX-2 and FAAH inhibitors

#102
20050002859
2005-01-06

COX-2-targeted imaging agents